Cleared Traditional

K061166 - DEEPWAVE PERCUTANEOUS NEUROMODULATION PAIN THERAPY SYSTEM (FDA 510(k) Clearance)

Aug 2006
Decision
110d
Days
Class 2
Risk

K061166 is an FDA 510(k) clearance for the DEEPWAVE PERCUTANEOUS NEUROMODULATION PAIN THERAPY SYSTEM. This device is classified as a Stimulator, Nerve, Electrical, Percutaneous (pens), For Pain Relief (Class II - Special Controls, product code NHI).

Submitted by Biowave Corporation (North Attleboro, US). The FDA issued a Cleared decision on August 15, 2006, 110 days after receiving the submission on April 27, 2006.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5890. Percutaneous Electrical Nerve Stimulator (pens) Is A Device Used For The Treatment Of Pain. Unlike The Classified Transcutaneous Electrical Nerve Stimulator That Apply An Electrical Current To Electrodes On A Patient's Skin To Deliver Stimulation, A Pens Uses Electrodes That Are Placed Percutaneously To Deliver Stimulation,.

Submission Details

510(k) Number K061166 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 27, 2006
Decision Date August 15, 2006
Days to Decision 110 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code NHI - Stimulator, Nerve, Electrical, Percutaneous (pens), For Pain Relief
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5890
Definition Percutaneous Electrical Nerve Stimulator (pens) Is A Device Used For The Treatment Of Pain. Unlike The Classified Transcutaneous Electrical Nerve Stimulator That Apply An Electrical Current To Electrodes On A Patient's Skin To Deliver Stimulation, A Pens Uses Electrodes That Are Placed Percutaneously To Deliver Stimulation,